Invariant NKT cells in adrenoleukodystrophy patients and mice

Journal of Neuroimmunology

Volumn 229, Issue 1-2, 2010, Pages 204-211

  Gautron, A S ^a   Giquel, B ^a   Beaudoin, L ^a   Autrusseau, E ^a   Speak, A ^b   Platt, F ^b   Kemp, S ^c   Pujol, A ^d,e   Aubourg, P ^a   Lehuen, A ^a  

^a INSERM   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Adrenoleukodystrophy; CD1d; CNS; INKT cells; LSD

Indexed keywords

CD1D ANTIGEN; GANGLIOSIDE;

ACYLATION; ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CELL SURFACE; CHILD; CONTROLLED STUDY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NATURAL KILLER CELL; NEUROPATHOLOGY; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; AGED; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1; ANTIGENS, CD1D; BREFELDIN A; CHILD; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GLYCOPROTEINS; GLYCOSPHINGOLIPIDS; HUMANS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NATURAL KILLER T-CELLS; PROTEIN SYNTHESIS INHIBITORS; YOUNG ADULT;

EID: 78650190142     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.09.003     Document Type: Article

References (37)

1. Araki M., Kondo T., Gumperz J.E., Brenner M.B., Miyake S., Yamamura T. Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int. Immunol. 2003, 15:279-288.
2. Balreira A., Lacerda L., Miranda C.S., Arosa F.A. Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model. Br. J. Haematol. 2005, 129:667-676.
3. Balreira A., Macedo M.F., Girao C., Rodrigues L.G., Oliveira J.P., Sa Miranda M.C., Arosa F.A. Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients. Br. J. Haematol. 2008, 143:601-604.
4. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
5. Brigl M., Brenner M.B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004, 22:817-890.
6. Dellabona P., Casorati G., Friedli B., Angman L., Sallusto F., Tunnacliffe A., Roosneek E., Lanzavecchia A. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset. J. Exp. Med. 1993, 177:1763-1771.
7. Exley M., Garcia J., Wilson S.B., Spada F., Gerdes D., Tahir S.M., Patton K.T., Blumberg R.S., Porcelli S., Chott A., Balk S.P. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 2000, 100:37-47.
8. Gadola S.D., Silk J.D., Jeans A., Illarionov P.A., Salio M., Besra G.S., Dwek R., Butters T.D., Platt F.M., Cerundolo V. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 2006, 203:2293-2303.
9. Gumperz J.E., Miyake S., Yamamura T., Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002, 195:625-636.
10. Illes Z., Kondo T., Newcombe J., Oka N., Tabira T., Yamamura T. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 2000, 164:4375-4381.
11. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 2001, 194:1789-1799.
12. Jayawardena-Wolf J., Benlagha K., Chiu Y.H., Mehr R., Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001, 15:897-908.
13. Kim C.H., Butcher E.C., Johnston B. Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 2002, 23:516-519.
14. Kojo S., Adachi Y., Keino H., Taniguchi M., Sumida T. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 2001, 44:1127-1138.
15. Lee P.T., Benlagha K., Teyton L., Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 2002, 195:637-641.
16. Lee P.T., Putnam A., Benlagha K., Teyton L., Gottlieb P.A., Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 2002, 110:793-800.
17. Linsen L., Thewissen M., Baeten K., Somers V., Geusens P., Raus J., Stinissen P. Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis. Arthritis Res. Ther. 2005, 7:R493-R502.
18. Lu J.F., Lawler A.M., Watkins P.A., Powers J.M., Moser A.B., Moser H.W., Smith K.D. A mouse model for X-linked adrenoleukodystrophy. Proc. Natl Acad. Sci. USA 1997, 94:9366-9371.
19. Mars L.T., Laloux V., Goude K., Desbois S., Saoudi A., Van Kaer L., Lassmann H., Herbelin A., Lehuen A., Liblau R.S. Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 2002, 168:6007-6011.
20. Mars L.T., Novak J., Liblau R.S., Lehuen A. Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks. Trends Immunol. 2004, 25:471-476.
21. Mars L.T., Gautron A.S., Novak J., Beaudoin L., Diana J., Liblau R.S., Lehuen A. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. J. Immunol. 2008, 181:2321-2329.
22. Matsuda J.L., Naidenko O.V., Gapin L., Nakayama T., Taniguchi M., Wang C.R., Koezuka Y., Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000, 192:741-754.
23. Mieza M.A., Itoh T., Cui J.Q., Makino Y., Kawano T., Tsuchida K., Koike T., Shirai T., Yagita H., Matsuzawa A., Koseki H., Taniguchi M. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 1996, 156:4035-4040.
24. Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., Poustka A.M., Mandel J.L., Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993, 361:726-730.
25. Neville D.C., Coquard V., Priestman D.A., te Vruchte D.J., Sillence D.J., Dwek R.A., Platt F.M., Butters T.D. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal. Biochem. 2004, 331:275-282.
26. Plati T., Visigalli I., Capotondo A., Buono M., Naldini L., Pia Cosma M., Biffi A. Development and maturation of invariant natural killer T cells in the presence of lysosomal engulfment. Eur. J. Immunol. 1996, 39:2749-2754.
27. Powers J.M., DeCiero D.P., Ito M., Moser A.B., Moser H.W. Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J. Neuropathol. Exp. Neurol. 2000, 59:89-102.
28. Pujol A., Hindelang C., Callizot N., Bartsch U., Schachner M., Mandel J.L. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum. Mol. Genet. 2002, 11:499-505.
29. Sagiv Y., Hudspeth K., Mattner J., Schrantz N., Stern R.K., Zhou D., Savage P.B., Teyton L., Bendelac A. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J. Immunol. 2006, 177:26-30.
30. Schrantz N., Sagiv Y., Liu Y., Savage P.B., Bendelac A., Teyton L. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J. Exp. Med. 2007, 204:841-852.
31. Schumann J., Facciotti F., Panza L., Michieletti M., Compostella F., Collmann A., Mori L., De Libero G. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur. J. Immunol. 2007, 37:1431-1441.
32. Singh A.K., Wilson M.T., Hong S., Olivares-Villagomez D., Du C., Stanic A.K., Joyce S., Sriram S., Koezuka Y., Van Kaer L. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 2001, 194:1801-1811.
33. Spada F.M., Borriello F., Sugita M., Watts G.F., Koezuka Y., Porcelli S.A. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur. J. Immunol. 2000, 30:3468-3477.
34. Sumida T., Sakamoto A., Murata H., Makino Y., Takahashi H., Yoshida S., Nishioka K., Iwamoto I., Taniguchi M. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J. Exp. Med. 1995, 182:1163-1168.
35. Valianpour F., Selhorst J.J., van Lint L.E., van Gennip A.H., Wanders R.J., Kemp S. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Mol. Genet. Metab. 2003, 79:189-196.
36. van der Vliet H.J., von Blomberg B.M., Nishi N., Reijm M., Voskuyl A.E., van Bodegraven A.A., Polman C.H., Rustemeyer T., Lips P., van den Eertwegh A.J., Giaccone G., Scheper R.J., Pinedo H.M. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 2001, 100:144-148.
37. Zhou D., Mattner J., Cantu C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., Teneberg S., Wang D., Proia R.L., Levery S.B., Savage P.B., Teyton L., Bendelac A. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306:1786-1789.